PRODH

proline dehydrogenase 1

Basic information

Region (hg38): 22:18912777-18936553

Links

ENSG00000100033NCBI:5625OMIM:606810HGNC:9453Uniprot:O43272AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hyperprolinemia type 1 (Strong), mode of inheritance: AR
  • hyperprolinemia type 1 (Definitive), mode of inheritance: AR
  • hyperprolinemia type 1 (Supportive), mode of inheritance: AR
  • hyperprolinemia type 1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hyperprolinemia, type IARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic13910064; 14497974; 4299764; 11510941; 12217952; 12525555; 17412540; 18197084; 18806117; 20524212; 23462603

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRODH gene.

  • Proline_dehydrogenase_deficiency (352 variants)
  • Schizophrenia_4 (142 variants)
  • not_provided (87 variants)
  • Inborn_genetic_diseases (20 variants)
  • not_specified (10 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRODH gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016335.6. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
81
clinvar
8
clinvar
93
missense
1
clinvar
2
clinvar
156
clinvar
11
clinvar
9
clinvar
179
nonsense
4
clinvar
2
clinvar
2
clinvar
1
clinvar
9
start loss
2
1
3
frameshift
6
clinvar
3
clinvar
1
clinvar
10
splice donor/acceptor (+/-2bp)
4
clinvar
2
clinvar
6
Total 11 13 166 92 18

Highest pathogenic variant AF is 0.00384334

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRODHprotein_codingprotein_codingENST00000357068 1423773
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.36e-120.35911613227293411257450.0390
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.06493073100.9900.00002023790
Missense in Polyphen91102.270.88981190
Synonymous-0.7921381271.090.000008681161
Loss of Function1.152127.50.7640.00000130333

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.1390.139
Ashkenazi Jewish0.04700.0469
East Asian0.03040.0304
Finnish0.02750.0274
European (Non-Finnish)0.03780.0376
Middle Eastern0.03040.0304
South Asian0.02440.0243
Other0.05330.0523

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts proline to delta-1-pyrroline-5-carboxylate.;
Disease
DISEASE: Hyperprolinemia 1 (HYRPRO1) [MIM:239500]: An inborn error of proline metabolism resulting in elevated levels of proline in the plasma and urine. The disorder is generally benign and most affected individuals are clinically asymptomatic. Some patients, however, have neurologic manifestations, including epilepsy and mental retardation. Association with certain forms of schizophrenia have been reported. {ECO:0000269|PubMed:12217952, ECO:0000269|PubMed:15662599, ECO:0000269|PubMed:17135275}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schizophrenia 4 (SCZD4) [MIM:600850]: A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder. {ECO:0000269|PubMed:11891283, ECO:0000269|PubMed:15662599}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Proline catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;Metabolism;proline degradation;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine (Consensus)

Intolerance Scores

loftool
0.707
rvis_EVS
1.74
rvis_percentile_EVS
96.63

Haploinsufficiency Scores

pHI
0.661
hipred
N
hipred_score
0.239
ghis
0.403

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.832

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prodh
Phenotype
pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
proline metabolic process;proline catabolic process;intrinsic apoptotic signaling pathway in response to oxidative stress;proline catabolic process to glutamate;positive regulation of cell death;4-hydroxyproline catabolic process;oxidation-reduction process
Cellular component
mitochondrion;mitochondrial inner membrane;mitochondrial matrix
Molecular function
proline dehydrogenase activity;FAD binding